

Sacral Nerve Stimulation (SNS) Devices Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Sacral Nerve Stimulation (SNS) Devices market is experiencing significant growth, driven by increasing prevalence of pelvic floor disorders. The market size is projected to reach approximately $400 million by 2025, with advancements in technology and rising adoption of minimally invasive procedures enhancing treatment options for patients with urinary and fecal incontinence. Request Sample Report
◍ Medtronic
◍ Boston Scientific
◍ Abbott
◍ Axonics Modulation Technologies
◍ Nuvectra
◍ Cogentix Medical
◍ Cyberonics
◍ Uroplasty, Inc
◍ Neuropace
◍ IntraPace, Inc
◍ Codman & Shurtleff, Inc
The Sacral Nerve Stimulation (SNS) Devices Market features key players like Medtronic, Boston Scientific, and Abbott, driving advancement through innovative devices for bladder and bowel control. Companies enhance market growth by expanding product portfolios, investing in R&D, and improving patient outcomes. Sales revenues include:
- Medtronic: $30 billion (2022)
- Boston Scientific: $12 billion (2022)
- Abbott: $43 billion (2022)
Request Sample Report
Hospitals
Clinics
Other
Request Sample Report
Implantable VNS Devices
External VNS Devices
Request Sample Report
$ X Billion USD